The marketing applications with the EMA and FDA are for J&J and partner Genmab's Darzalex Faspro version of the anti-CD38 ...

Our US patent will now expire on February 5th ... agreement with Nobelpharma for the development and commercialization of ...

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, ...

USGBC accelerates and scales transformation of the built environment to minimize climate impacts and enhance the well-being of people, the environment and communities worldwide.